Odyssey Group International (Odyssey Group International) LT-Debt-to-Total-Asset : 0.00 (As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Odyssey Group International LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Odyssey Group International's long-term debt to total assests ratio for the quarter that ended in Jan. 2024 was 0.00.

Odyssey Group International's long-term debt to total assets ratio stayed the same from Jan. 2023 (0.00) to Jan. 2024 (0.00).

Odyssey Group International LT-Debt-to-Total-Asset Historical Data

The historical data trend for Odyssey Group International's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Odyssey Group International LT-Debt-to-Total-Asset Chart

Odyssey Group International Annual Data

Trend

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.47

Odyssey Group International Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Odyssey Group International LT-Debt-to-Total-Asset Calculation

Odyssey Group International's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jul. 2023 is calculated as

LT Debt to Total Assets (A: Jul. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Jul. 2023 )	/	Total Assets (A: Jul. 2023 )
	=	0	/	0.456
	=

Odyssey Group International's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jan. 2024 is calculated as

LT Debt to Total Assets (Q: Jan. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jan. 2024 )	/	Total Assets (Q: Jan. 2024 )
	=	0	/	14.05
	=

Odyssey Group International (OTCPK:ODYY) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Odyssey Group International LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Odyssey Group International's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Odyssey Group International (Odyssey Group International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Odyssey Group International Inc (OTCPK:ODYY) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

2300 West Sahara Avenue, Suite 800 - No. 4012, Las Vegas, NV, USA, 89102

Website

https://www.odysseyhealthinc.com

Odyssey Group International Inc is a company focused on developing life-saving medical products, Odyssey's goal is to create, acquire and accumulate distinct assets, intellectual property, and technologies that provide meaningful medical solutions. The Company is focused on building and acquiring assets in areas that have an identified technological advantage, provide superior clinical utility, and have a substantial market opportunity.

Executives

Erik C. Emerson	other: Chief Commercial Officer	2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Gregory W Gironda	other: Chief Operating Officer	2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Ricky Richardson	director	2372 MORSE AVE., IRVINE CA 92614
Christine Farrell	officer: Controller/Secretary	2372 MORSE AVE, IRVINE CA 92614
John P Gandolfo	director	62 TERRACE ROAD, WAYNE NJ 07470
Jerome H Casey	director	2372 MORSE AVE, IRVINE CA 92614
Jeffrey X Conroy	director	2372 MORSE AVE, IRVINE CA 92614
Vanlandingham Jacob Ph.d	director	2372 MORSE AVE, IRVINE CA 92614
J Michael Redmond	director, officer: President/CEO	10 CANTERBURY ROAD, WINDHAM NH 03087